EMEA INSPIRED BY FAILED LONDON MEDICAL TESTS TO PROPOSE HUMAN TRIAL SAFETY GUIDELINES
April 1st, 2007
BY KEITH NUTHALLTHE DISASTROUS medical trials at London's Northwick Park Hospital have now sparked the development by the European Medicines Agency (EMEA) of draft guidelines for first-in-man clinical trials of potentially high-risk medicinal products. London-based EU agency EMEA's advice outlines information researchers should gather prior to a human trial, ranging from a product characterisation, a determination of its strength and potency, detailed information on how the medicine will interact with the body, and the length of its effects.Another key element is ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.